✨ Free AI Report
PROCEPT BioRobotics Corporation: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research PROCEPT BioRobotics Corporation
Company Research

PROCEPT BioRobotics Corporation: Business Overview, Financials & Competitive Analysis

PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company has demonstrated strong clinical impact with more than 125,000 patien...

Analyst-debate audio for PROCEPT BioRobotics Corporation

AskCyborg analysts argue the bull and bear cases for PROCEPT BioRobotics Corporation across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
8/ 10Strong

Cyborg Score thesis

PROCEPT is a well-positioned robotic urology company with strong procedure growth momentum, clear path to profitability, and...

Read the full analyst-debate transcript →
Industry Medical Devices - Robotic Surgical Systems / Urology
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest PROCEPT BioRobotics Corporation Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

PROCEPT BioRobotics Corporation Overview

Pro stress-test →

PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company has demonstrated strong clinical impact with more than 125,000 patients treated to date, positioning itself as a critical player in the robotic urology treatment space.

Strategic Profile

Pro stress-test →

The company's Aquablation therapy is designed to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) independent of prostate size and shape or surgeon experience. With current Aquablation market penetration at approximately 10% of the treated market where roughly 400,000 patients per year undergo prostate procedures, PROCEPT has substantial headroom for growth from millions of men on drug therapy.

Competitive Landscape

Pro stress-test →

PROCEPT operates in the robotic urology market competing against established surgical robotics players and traditional treatment approaches. The company differentiates through its proprietary Aquablation technology using high-velocity water jet precision, AI-powered automation, and clinical evidence demonstrating superior outcomes. With only ~10% market penetration in its addressable BPH market and significant reimbursement advantages, PROCEPT has substantial competitive positioning advantage as it scales.

Industry Context

PROCEPT BioRobotics Corporation operates in Medical Devices - Robotic Surgical Systems / Urology.

Key facts

Headquarters: San Jose, California · Revenue: $390-$410M (2026 guidance)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on PROCEPT BioRobotics Corporation.

  • Record Q4 2025 performance with approximately 12,200 procedures and 65 new system sales marking the company's strongest capital quarter
  • Pricing discipline improvements with handpiece average selling prices expected to rise to approximately $3,500 in 2026 through elimination of quarter-end discounts
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Hosted 2026 Investor Day outlining multi-year growth strategy with $390-$410M revenue guidance for 2026
  • February 2026Q4 2025 record procedure volume of ~12,200 procedures and 65 new system sales
  • +1 moreTrack every material event for PROCEPT BioRobotics Corporation as it happens. Explore monitoring →
Get alerted when PROCEPT BioRobotics Corporation has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

da Vinci Surgical SystemGeneral-purpose robotic surgery platform used across multiple surgical specialties including urology→Traditional Surgical ApproachesTURP and open prostatectomy procedures for BPH treatment→Laser-based TreatmentsLaser prostate ablation procedures for BPH→

Compare PROCEPT BioRobotics Corporation with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

PROCEPT BioRobotics Corporation operates in Medical Devices - Robotic Surgical Systems / Urology. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Robotic Surgical Systems / Urology research →
NEW · MCP server

Ask your AI assistant about PROCEPT BioRobotics Corporation

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare PROCEPT BioRobotics Corporation and its top competitor on Cyborg Score”
“What did PROCEPT BioRobotics Corporation do this quarter?”
“Is PROCEPT BioRobotics Corporation a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does PROCEPT BioRobotics Corporation do?+
PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company has demonstrated strong clinical impact with more than 125,000 patien...
What is PROCEPT BioRobotics Corporation's Cyborg Score?+
PROCEPT BioRobotics Corporation has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are PROCEPT BioRobotics Corporation's main competitors?+
Named competitors include da Vinci Surgical System, Traditional Surgical Approaches, Laser-based Treatments. The full competitive landscape is in the AskCyborg report.
How can I get the full PROCEPT BioRobotics Corporation research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the PROCEPT BioRobotics Corporation research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track PROCEPT BioRobotics Corporation over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.